<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD05930000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q13114</UniProt_ID>
  <Seq_Length>568</Seq_Length>
  <Molecule_Weight>64490</Molecule_Weight>
  <KEGG_ID>hsa:7187</KEGG_ID>
  <Orthology_ID>K03174</Orthology_ID>
  <EBI_ID>EBI-357631</EBI_ID>
  <Function_Summary>Regulates pathways leading to the activation of NF-kappa-B and MAP kinases, and plays a central role in the regulation of B-cell survival. Part of signaling pathways leading to the production of cytokines and interferon. Required for normal antibody isotype switching from IgM to IgG. Plays a role T-cell dependent immune responses. Plays a role in the regulation of antiviral responses. Is an essential constituent of several E3 ubiquitin-protein ligase complexes. May have E3 ubiquitin-protein ligase activity and promote 'Lys-63'-linked ubiquitination of target proteins. Inhibits activation of NF-kappa-B in response to LTBR stimulation. Inhibits TRAF2-mediated activation of NF-kappa-B. Down-regulates proteolytic processing of NFKB2, and thereby inhibits non-canonical activation of NF-kappa-B. Promotes ubiquitination and proteasomal degradation of MAP3K14.</Function_Summary>
  <Pfam_ID>PF00917:MATH</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>CD40 receptor-associated factor 1</Alias>
      <Alias>LAP1</Alias>
      <Alias>CRAF1</Alias>
      <Alias>CD40BP</Alias>
      <Alias>CD40-binding protein</Alias>
      <Alias>CAP-1</Alias>
      <Alias>LMP1-associated protein 1</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + ubiquitin + protein lysine = AMP + diphosphate + protein N-ubiquityllysine.</Detail>
      <Keyword>Ubiquitin-protein ligase activity</Keyword>
      <Ontology_ID>GO:0004842</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).</Detail>
      <Keyword>Protein binding</Keyword>
      <Ontology_ID>GO:0005515</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Conveys a signal across a cell to trigger a change in cell function or state. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.</Detail>
      <Keyword>Signal transducer activity</Keyword>
      <Ontology_ID>GO:0004871</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with zinc (Zn) ions.</Detail>
      <Keyword>Zinc ion binding</Keyword>
      <Ontology_ID>GO:0008270</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the joining of two substances, or two groups within a single molecule, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.</Detail>
      <Keyword>Ligase activity</Keyword>
      <Ontology_ID>GO:0016874</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>129</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.</Detail>
      <Keyword>Negative regulation of type I interferon production</Keyword>
      <Ontology_ID>GO:0032480</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.</Detail>
      <Keyword>Innate immune response</Keyword>
      <Ontology_ID>GO:0045087</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in immunity, any immune system process that functions in the response of an organism to a potential internal or invasive threat. The vertebrate immune system is formed by the innate immune system (composed of phagocytes, complement, antimicrobial peptides, etc) and by the adaptive immune system which consists of T- and B-lymphocytes.</Detail>
      <Keyword>Immunity</Keyword>
      <Ontology_ID>KW-0391</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any series of molecular signals generated as a consequence of binding to a toll-like receptor. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.</Detail>
      <Keyword>Toll-like receptor signaling pathway</Keyword>
      <Ontology_ID>GO:0002224</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process that directly activates any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Induction of apoptosis</Keyword>
      <Ontology_ID>GO:0006917</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the antiviral response of a cell or organism.</Detail>
      <Keyword>Regulation of defense response to virus</Keyword>
      <Ontology_ID>GO:0050688</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor NF-kappaB.</Detail>
      <Keyword>Negative regulation of NF-kappaB transcription factor activity</Keyword>
      <Ontology_ID>GO:0032088</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in ubiquitin-like modifier processing, activation, conjugation or deconjugation such as Ubl-activating enzymes (E1s), Ubl-conjugating enzymes (E2s), Ubl-protein ligases (E3s), some thiol proteases (Ubiquitin carboxyl-terminal hydrolases (UCH), Ubiquitin-specific processing proteases (UBP) and ubiquitin-like proteases) and the ubiquitin-like modifier proteins. Besides signaling proteolysis, ubiquitination for example can be a signal for trafficking, kinase activation and other nonproteolytic fates.</Detail>
      <Keyword>Ubl conjugation pathway</Keyword>
      <Ontology_ID>KW-0833</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein.</Detail>
      <Keyword>Regulation of proteolysis</Keyword>
      <Ontology_ID>GO:0030162</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate, or extent of interferon-beta production.</Detail>
      <Keyword>Regulation of interferon-beta production</Keyword>
      <Ontology_ID>GO:0032648</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor.</Detail>
      <Keyword>Tumor necrosis factor-mediated signaling pathway</Keyword>
      <Ontology_ID>GO:0033209</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MESSKKMDSPGALQTNPPLKLHTDRSAGTPVFVPEQGGYKEKFVKTVEDKYKCEKCHLVLCSPKQTECGHRFCESCMAALLSSSSPKCTACQESIVKDKVFKDNCCKREILALQIYCRNESRGCAEQLMLGHLLVHLKNDCHFEELPCVRPDCKEKVLRKDLRDHVEKACKYREATCSHCKSQVPMIALQKHEDTDCPCVVVSCPHKCSVQTLLRSELSAHLSECVNAPSTCSFKRYGCVFQGTNQQIKAHEASSAVQHVNLLKEWSNSLEKKVSLLQNESVEKNKSIQSLHNQICSFEIEIERQKEMLRNNESKILHLQRVIDSQAEKLKELDKEIRPFRQNWEEADSMKSSVESLQNRVTELESVDKSAGQVARNTGLLESQLSRHDQMLSVHDIRLADMDLRFQVLETASYNGVLIWKIRDYKRRKQEAVMGKTLSLYSQPFYTGYFGYKMCARVYLNGDGMGKGTHLSLFFVIMRGEYDALLPWPFKQKVTLMLMDQGSSRRHLGDAFKPDPNSSSFKKPTGEMNIASGCPVFVAQTVLENGTYIKDDTIFIKVIVDTSDLPDP</Protein_Seq>
    <DNA_Seq>GGGAGCGCGGCGCGGCCGCCGCGTGCGCGAGCCGGGGTTGCAGCCCAGCCGGGACTTTCCAGCCGGCGGCAGCCGCGGCGGCCGCCGGCTCTTCCCCGCCCCCCGCCATGGGGCAGCCCGGGGAGCAGAACGCTGCGGACCGCGGCGGAGGACGCGCCCGGCGCCCCTGAGCCGGCCGAGCGGCGACGGACCGCGAGAACTCCTCTTTCCTAAAATGGAGTCGAGTAAAAAGATGGACTCTCCTGGCGCGCTGCAGACTAACCCGCCGCTAAAGCTGCACACTGACCGCAGTGCTGGGACGCCAGTTTTTGTCCCTGAACAAGGAGGTTACAAGGAAAAGTTTGTGAAGACCGTGGAGGACAAGTACAAGTGTGAGAAGTGCCACCTGGTGCTGTGCAGCCCGAAGCAGACCGAGTGTGGGCACCGCTTCTGCGAGAGCTGCATGGCGGCCCTGCTGAGCTCTTCAAGTCCAAAATGTACAGCGTGTCAAGAGAGCATCGTTAAAGATAAGGTGTTTAAGGATAATTGCTGCAAGAGAGAAATTCTGGCTCTTCAGATCTATTGTCGGAATGAAAGCAGAGGTTGTGCAGAGCAGTTAATGCTGGGACATCTGCTGGTGCATTTAAAAAATGATTGCCATTTTGAAGAACTTCCATGTGTGCGTCCTGACTGCAAAGAAAAGGTCTTGAGGAAAGACCTGCGAGACCACGTGGAGAAGGCGTGTAAATACCGGGAAGCCACATGCAGCCACTGCAAGAGTCAGGTTCCGATGATCGCGCTGCAGGTTTCCTTGTTGCAGAATGAAAGTGTAGAAAAAAACAAGAGCATACAAAGTTTGCACAATCAGATATGTAGCTTTGAAATTGAAATTGAGAGACAAAAGGAAATGCTTCGAAATAATGAATCCAAAATCCTTCATTTACAGCGAGTGATAGACAGCCAAGCAGAGAAACTGAAGGAGCTTGACAAGGAGATCCGGCCCTTCCGGCAGAACTGGGAGGAAGCAGACAGCATGAAGAGCAGCGTGGAGTCCCTCCAGAACCGCGTGACCGAGCTGGAGAGCGTGGACAAGAGCGCGGGGCAAGTGGCTCGGAACACAGGCCTGCTGGAGTCCCAGCTGAGCCGGCATGACCAGATGCTGAGTGTGCACGACATCCGCCTAGCCGACATGGACCTGCGCTTCCAGGTCCTGGAGACCGCCAGCTACAATGGAGTGCTCATCTGGAAGATTCGCGACTACAAGCGGCGGAAGCAGGAGGCCGTCATGGGGAAGACCCTGTCCCTTTACAGCCAGCCTTTCTACACTGGTTACTTTGGCTATAAGATGTGTGCCAGGGTCTACCTGAACGGGGACGGGATGGGGAAGGGGACGCACTTGTCGCTGTTTTTTGTCATCATGCGTGGAGAATATGATGCCCTGCTTCCTTGGCCGTTTAAGCAGAAAGTGACACTCATGCTGATGGATCAGGGGTCCTCTCGACGTCATTTGGGAGATGCATTCAAGCCCGACCCCAACAGCAGCAGCTTCAAGAAGCCCACTGGAGAGATGAATATCGCCTCTGGCTGCCCAGTCTTTGTGGCCCAAACTGTTCTAGAAAATGGGACATATATTAAAGATGATACAATTTTTATTAAAGTCATAGTGGATACTTCGGATCTGCCCGATCCCTGATAAGTAGCTGGGGAGGTGGATTTAGCAGAAGGCAACTCCTCTGGGGGATTTGAACCGGTCTGTCTTCACTGAGGTCCTCGCGCTCAGAAAAGGACCTTGTGAGACGGAGGAAGCGGCAGAAGGCGGACGCGTGCCGGCGGGAGGAGCCACGCGTGAGCACACCTGACACGTTTTATAATAGACTAGCCACACTTCACTCTGAAGAATTATTTATCCTTCAACAAGATAAATATTGCTGTCAGAGAAGGTTTTCATTTTCATTTTTAAAGATCTAGTTAATTAAGGTGGAAAACATATATGCTAAACAAAAGAAACATGATTTTTCTTCCTTAAACTTGAACACCAAAAAAACACACACACACACACACGTGGGGATAGCTGGACATGTCAGCATGTTAAGTAAAAGGAGAATTTATGAAATAGTAATGCAATTCTGATATCTTCTTTCTAAAATTCAAGAGTGCAATTTTGTTTCAAATACAGTATATTGTCTATTTTTAAGGCCTCATCTGGTCTCTGTTTTAATAATTTGTTTGTCAGAAGACCCTGAAGTATATACCTAGGTCTTTTTTTTGAAAGTCTCTAAATTCAGAATCATTTTTTAATTTAAAGTTCTACAAATAATTGTTACTGCAAACATTTTATTTTAAAACGTTGATAGACTGATATTTCTTGGAAGAAAATATAAAATATCAAACACTGGTTATCACTTGTGATAGGAAAGAGAATATTCAACCTGTTGTTATTTCTCGTTAGAAATGTAAACCTTCAAATATCTGTCGTAGTTAATGACACGACTTCACAATTCTGAACGGAGCCTCGCTCATGGATGCTGTGCATCATTTTCAGATTTATAATTGTTTTCACCCTAAAATAGGGCATCCGTTGAACTTTGGAGTTCTAAACAAAATCCTGTAGGTGTTTGGATTCTGCCCCATGTGTTCGGACGAGCTCTCTGTTGCTGACAGCACCGGCCTTCGGTCTCCATGTCAGGGGTGGGCGGGTGACTGCTGAGGGAGGCCCGCAGGTGTGTTTCTCCATCCCGTCATCTTGCTGCATGCCGTCAACGGTCTCCGAAAGCAACGTTGTGCGTAGAGCTGGTGGCATACGGCCCACGTGCCTTAGATGGGACATGCTGCTTCTCCACCCTGGGTTTGCATTGAGCATCATTCTAGAAAGTGCTAGTTTAACCAGACTTTTCTCTCCACCACTAGATCTTTGTCTCTACAAGGGCCCTCAGACACCTCTGCACCTGCTGAGGGGAAGCCAGGCTCCACCGTCGGCTTCTGGAGCCTCCGCTGCTTAATTACCACAGATTCCAAATCTCTAGGCCCCACGAGTGAGCCGCCTGGTCCAAGTACGGCCTGGTCCCACCCTGAGGGAGGCAGGTGTGGAACAGAAGCCGAGCCTCTCCGTGTCCCCACCGGGGCCGTGGGCACCCCCACAGCCCGAAGCAGAACCCTCTGAGCATTCCAGAGACCGCTGCTCGGGGGCCTGCCCAGGCTGACCAACGGGCGCTCCTGACCACCACCCTGGCGGGAAGGGTGGCCACGGGGCCCGTCGTCCCAGCCTGTGCCTGCCCAGATGGCATTTTCTCAACTCACTGTTTACTGTCTCTCAGTGTCCAACTGTGATTAGAAGCCTGGAGCCTGCCCCCTGCACCCCTTTTGCTATGCACCACGCTTCATGGTGCTCTTACCACTGATGGGTGCTACACGCGACGGGTGCTTCTTAGGCAAAACCAATGTGTGCGAACTGTCACACCTGTGCCACTCGCCCACAAGCCGCGCCCACAATTGGCCAGCTGGGCCGTGCACGTCAGACTGCCTGCCTCGGCTCTCCCCGTGGCCGCGCGGGGACAGCTTGGTGGGTGCCCGGTGGCCCACCTGTCTCTGGTGCTGCCATCTGTCCTGGGTGTGCCTTCGCCCCAGTGCCTGCTGGAAGTGCCCTCCGTCGCACCCCTGTGCCCTGAGCTCCCGTGAGGGGCCCGCCGCGCCCTTTCGCGGTCGAAGCGTTCCGTTGTTCTTATCTGCCTTTCCTTTCCCCGCTCTCCTGGGATTACTTTGGGGGAATGAGTATCCTTGGTTCTGCCCTGTGAGGGAGTCGTGTGTCCCTGCTCATAAAGGAAGGACTTCCTGCAGAAGCTGCGGAAAACTACTGTTCCCTCGAAGGTGTCCCCCACCTGAGGCCTGTCCCCTACCTGCCCTCAGGTAGTTTTCCTGAGGCCAGGGGTTAACAACAGGGACATCCCTGCAACTTCCCCTTCACAAAATGTATAATATTAGATGAAGGATATGCAACATCTTGGTCTAGTAAGAACCGTTTCCTCCCCTCTGGGTTGAAGTCCTGGTGTGGCCCCCAGAAGCAGCAGTGCGTGTCACTGGGACGTCTCCAGTAGCCCTTCCCAGGCAGACGCTCCTGGCGGGACGCCATGGGGCCCACCTGAGGGTCCCACAGACGTAACCTGAGTGACAGGAGTCCTTGAGGATGGGATGGCCTATGTCACACACTTTGTCCTTGAACCTGAGTGATGGGGGTCCTTGAGGATGGGATGGCCTGTGTCACGCGCTTTGTCTTTGTGTTTGGTTGTATCGGGGTCTCTGTTCTGAGTGTGTCTTCCTCTCATGTACTCAACACAGTGGGCAGCAGCCTGGGACGGCGTCCCCTCTCCCGGCGGCGGGCAAGCCTTGCGCTGCTCCACCCTCGGCCTGGGCACCCTCACTTGGCGCTGGCCACCTGGGCCAGCCTGGGGCCATGGTCTCTCTGCAGCTGAGGCCCAGTGGCCCCTTGGGCAGTGATCGGCCCTCCCCGCATCACAGGGCCCTGGCAGCAAGCGGGAAATGGGGGCGCACACTGTGTGCTTGGGGGTGCTGCTTGTTTACCACACATGACCAGACTCCCAGCAGGACAGAGCTGCTCAGTACTTTACAGAAACCAACTGAGTCGTTTGTGCATGAATTAAGCCGGTCTGCTTCCCCGTCACCTTCGTAACAAAACAACGTCCCCTCTCCCCTCGCCTCGAGCAGTTTCTTCAGGACACCGTGGCTCGGGCTGCTCCCTGCTGCCAGGCACGCTGGTTGGCTGGCCTGGGCCCGGCTCACGTGAAGGGCACTGGCTCTTGTGACCACACTGAGCCACGTGCAAGCCGCAGCCGGGCCTGGAAGCCTGACCCTCTGGTTCTAGGGCTTGTCCCGCGGAGCCTGCAGAGCTAGACGTTGGGGTGTGTCCGTGATGATATGGGGGCCAGGCTGGGAGTAGGGCCTTTCTAGCAGGGTTGGGTGGCTCAGTGAGGGTGTGGAAGTGGGGGACCCACGGGGCCTGGCTTTGGGACTAGACATGCCAGCCCCAGCTGGGCTGGAGGGAGCCTGAGTGAGCCCCGACATACGCTGGGCCTTTCAGCTCGCCGTGCTCTGGTGACACACAGGCGGCCAGGTTGGGATTTGTGTCAATTCTAGGAGCCATCAAGCATGAATGTGGTTCTGTCTCCTGAGCGCAAGCCTCGCCGGACCCCTGGGCGAAGGCCTGGACTTGCAGATGTGTGTTCCCTGTGCGGGTGGACAGAGGGGGCCCTTATGACCCACATTGCAGCCCCATTCCACCACCCCTTCCTCCCCAGAGCAGTCTCTGCCGAGGGACAGCACCTGTGTCCCTTCGATGCCACAACAGCCAGTTGAACAGGGGAGCCCTTTGCTCAGGCAGCTTCTCCTGCCTCTCCCTCCTTTCTCCTTCCCTGCCCCATCCCCGTGCCCTTCTTGGCCTGTGGCGCTGGGGAGCCATGGTGTGGCATACTGGGGCTCCTGCTCCTTGGGCCACTTCCTCAGCCCGGGCCCCACAGGCCCACCACCTGCCAGGGCTCCCACTGCACTGGCTGTGGCAGGAGGCTTCCCCATGACCCCGTGTGGCCCAGCTCGGTGAGGATGCAGTTCTAGGCACAGCCCCTGGGACAGCCAGCTGCCTCCCAGACCACGTCAGCCTGCTCCAGGGTCCTCAGTCACCCTGGGCCAGGGGCCACGTGTCCCATGGATGTCGACCATGCCAACGTCACATTCCAGCACCCCTTTTGCTTGATGGCGTCTGGTGGTAGTCAGCATGGTGGACCCACATCCTACAGCCAGAGGTGATGTTGGACAAAGGAAGGGGAGTCTGGATGGGTCCTTAAACGACCATTCTGTCCGCAGCGGGGTCATTCCTTGTCAGCCCAAGGGAGGGCCGGGGAGTACACTGATCCCAACAGCTGGGCTGACACCTCCTTTCTCCCCTGCACGGGGAGGATTGGCCTGAGGACCGTCACCCTGTGCACAGCCCCAGTAGGGTGGCAGTGCCACTGTCTCCTTGGGCCGTTGCAGGATTGGGCGGGTGCAGACTCCCCTTGCGGGCCCCTTGCTCAATCCCCGGCCCTCCCAGACTCCTCCCTCTACTGGGGGTAATTTGTGTGTCAGAAGGGCTCTGGCAGAGCTGTAAAATACTGTTTTTTAAAAATTTTAGTCCAGATCTTTACTTATTAGACTGCAGAAGGAGAGCTAGGGAGAGTGGGGGAAGCCCCCTTGCTTTTGTATCTGTGAGGTGAATGAGGGTCTGTCACCCAAATCTACTTCTCAGCCCATGACCATAGTTCTGTTTTCCGTTTGCAAATCTCAGTAGCTCTGTTTTCTCCAAAGTAGAATGTGCGCACCGGGGTCCTAGCCAGGCGAGGTCAGTGTCGGCAGGCTACCTGGTCATTATTGCTGCCTCGTCCAGGCTGATGCTGATGGTCACAGGCACGGTGGCATCAGGGAGCCGGGCCAGCAGGCGGCGTGAGGCGGGGCCAGCAGCTCACTGCAAGGGCATTTTCCACCTGATCCTGGTGTGCCCCACATGCGGTGGCAGGGCAGACGTGTGAAGCCTCGGCCGTCTCGGGGCTGGCAGGTGTGCGGGTGAGGAGGCCCCGGTGGCCAAGCAGAGCCTGCGTTTCATTTCTCCTGCTGCACTGTGTCTAGTCTGTCTTGTGAACTCTCACCGTGAAAAGAGGCTAGAAGTCCAGGATCGCTGTACCGCTCCTGTAATTAGGTGATGACTGGATTTGACAACTTAGTCCCCTCAGACAAGTAAGATACCCTCCAACAGCAAATTCAATGACTTAATTGGAAAACACACAAGCTGGCATGATGTCCGGTGATTTCTGTAAGAAATGCCTGTAGGAGAAGGTCTGTGAAGTGTGGAGGGCAGTGTCGACGCTGCACAGCATCTGCAGATTCGCAGCCTCTTCTCTGCCGGTGCCTCTGTTCGGTTCTGTTACCCAAAAACAAAGACCAAAGAAGGCCAATCTCTCATTTGACCCTGTCTTTTTAATCTGCCTGTTTTAAAAGTTGCGTCTGTAGTAGCCGCTTGCTGTGAAGACACATCTTGACAGTCCAAGTGATTTTGTGACCAGTGATTTGGGTCCTGTTTTCCGCTCTTCTAAGAAAAAACAAAAAGACCGTGAGTTATTGCCCAGCAATAATCATGTTGTTACTGTGAGTTAGCAACATGCCTGACTTCCTGATAGCATTACTGTTTTCTAGTTTTGTTTATTGTATATTATGTGTGGTTTTATTTGGTATTTATTTGTGTTTTGAGGTCTTGCAATGTTTTTGTGTTTCTGATGCTAATAACTAAAGTTTGTAAGACTGTAGAATGCAAAACTCGGAGATGCTAAACTGTCTTATTAGAGGAAAATAAATCTGATTATGGAGTCTCAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>CD40 receptor complex</CellLocal>
      <Ontology_ID>GO:0035631</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endosome</CellLocal>
      <Ontology_ID>GO:0005768</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Internal side of plasma membrane</CellLocal>
      <Ontology_ID>GO:0009898</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Mitochondrion</CellLocal>
      <Ontology_ID>GO:0005739</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytosol</CellLocal>
      <Ontology_ID>GO:0005829</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>TRAF3</Gene_Name>
    <Gene_Alias>CAP1; CRAF1</Gene_Alias>
    <Gene_ID>7187</Gene_ID>
    <Genbank_ACCN>NM_001199427</Genbank_ACCN>
    <Protein_ACCN>NP_001186356</Protein_ACCN>
    <HGNC_ID>12033</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/7187</Gene_URL>
    <UCSC_ID>uc010txy.2</UCSC_ID>
    <EMBL_ID>ENSG00000131323</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q8TDR0</Uniprot_ID>
      <Gene_Name>TRAF3IP1</Gene_Name>
      <EBI_ID>EBI-928811</EBI_ID>
      <PPI_EBI_URL>EBI-357631,EBI-928811</PPI_EBI_URL>
      <Experiment_Number>8</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q92844</Uniprot_ID>
      <Gene_Name>TANK</Gene_Name>
      <EBI_ID>EBI-356349</EBI_ID>
      <PPI_EBI_URL>EBI-357631,EBI-356349</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P25942</Uniprot_ID>
      <Gene_Name>CD40</Gene_Name>
      <EBI_ID>EBI-525714</EBI_ID>
      <PPI_EBI_URL>EBI-357631,EBI-525714</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Herpes Simplex Encephalitis 3</Disease_Name>
      <Disease_Detail>Herpes Simplex Encephalitis</Disease_Detail>
      <Disease_DB>HRP028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/herpes_simplex_encephalitis_3?search=TRAF3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Encephalitis</Disease_Name>
      <Disease_Detail>Encephalitis</Disease_Detail>
      <Disease_DB>ENC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/encephalitis?search=TRAF3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Herpes Simplex Encephalitis</Disease_Name>
      <Disease_Detail>Herpes Simplex Encephalitis</Disease_Detail>
      <Disease_DB>HRP009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/herpes_simplex_encephalitis?search=TRAF3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Herpes Simplex Encephalitis 1</Disease_Name>
      <Disease_Detail>Herpes Simplex Encephalitis</Disease_Detail>
      <Disease_DB>HRP023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/herpes_simplex_encephalitis_1?search=TRAF3#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Herpes Simplex</Disease_Name>
      <Disease_Detail>Herpes Simplex</Disease_Detail>
      <Disease_DB>HRP006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/herpes_simplex?search=TRAF3#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Key contacts promote recongnito of BAFF-R by TRAF3</PDB_Title>
      <PDB_ID>2GKW</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GKW</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation.</PubMed_Title>
      <Author>Ni, C.-Z., et al.</Author>
      <Journal>J.Immunol.(2004)173:7394-7400</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15585864?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structurally Distinct Recognition Motifs in Lymphotoxin-B Receptor and CD40 for TRAF-mediated Signaling</PDB_Title>
      <PDB_ID>1RF3</PDB_ID>
      <Resolution>3.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1RF3</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structurally distinct recognition motifs in lymphotoxin-beta receptor and CD40 for tumor necrosis factor receptor-associated factor (TRAF)-mediated signaling.</PubMed_Title>
      <Author>Li, C., et al.</Author>
      <Journal>J.Biol.Chem.(2003)278:50523-50529</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/14517219?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3</PDB_Title>
      <PDB_ID>1FLK</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FLK</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular basis for CD40 signaling mediated by TRAF3.</PubMed_Title>
      <Author>Ni, C.Z., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2000)97:10395-10399</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10984535?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>LMP1 Protein binds to TRAF3 as a structural CD40</PDB_Title>
      <PDB_ID>1ZMS</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1ZMS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>LMP1 protein from the Epstein Barr virus is a structural CD40 decoy in B lymphocytes fro binding to TRAF3</PubMed_Title>
      <Author>Wu, S.D., et al.</Author>
      <Journal>J.Biol.Chem.(2005)39:33620-33626</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16009714?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>MOLECULAR BASIS FOR CD40 SIGNALING MEDIATED BY TRAF3</PDB_Title>
      <PDB_ID>1FLL</PDB_ID>
      <Resolution>3.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1FLL</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Molecular basis for CD40 signaling mediated by TRAF3.</PubMed_Title>
      <Author>Ni, C.Z., et al.</Author>
      <Journal>Proc.Natl.Acad.Sci.USA(2000)97:10395-10399</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/10984535?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Solution structure of the Zinc finger, C3HC4 type (RING finger) domain of TNF receptor-associated factor 3</PDB_Title>
      <PDB_ID>2ECY</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2ECY</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Solution structure of the Zinc finger, C3HC4 type (RING finger)</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>DOWNSTREAM REGULATOR TANK BINDS TO THE CD40 RECOGNITION SITE ON TRAF3</PDB_Title>
      <PDB_ID>1KZZ</PDB_ID>
      <Resolution>3.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KZZ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Downstream regulator TANK binds to the CD40 recognition site on TRAF3.</PubMed_Title>
      <Author>Li, C., et al.</Author>
      <Journal>Structure(2002)10:403-411</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12005438?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>DOWNSTREAM REGULATOR TANK BINDS TO THE CD40 RECOGNITION SITE ON TRAF3</PDB_Title>
      <PDB_ID>1L0A</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1L0A</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Downstream regulator TANK binds to the CD40 recognition site on TRAF3.</PubMed_Title>
      <Author>Li, C., et al.</Author>
      <Journal>Structure(2002)10:403-411</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/12005438?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05169</Pathway_ID>
      <Pathway_Title>Epstein-Barr virus infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05168</Pathway_ID>
      <Pathway_Title>Herpes simplex infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05160</Pathway_ID>
      <Pathway_Title>Hepatitis C</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04622</Pathway_ID>
      <Pathway_Title>RIG-I-like receptor signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04620</Pathway_ID>
      <Pathway_Title>Toll-like receptor signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Immune system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05222</Pathway_ID>
      <Pathway_Title>Small cell lung cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04668</Pathway_ID>
      <Pathway_Title>TNF signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>All beta proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.c.be.b.b.c.html</SCOP_URL>
    <CATH_Class>Class 2: Mainly Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1flk</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Protein-induced</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>